
Okomera
We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity
http://www.okomera.com
11-50 employees
Growth Trajectory
Okomera, having recently raised €10.2m, is positioned to expand its personalized medicine development platform and further develop its high-throughput screening capabilities. Their focus on scalable CRISPR screening and combinatorial drug screening indicates potential for growth within the oncology market, potentially extending into other areas of personalized medicine.
Technical Challenges
Scaling standard 2D assays to 3D organoid on chip
High-throughput screening of organoids
Automation of organoid handling and analysis
Ensuring reproducibility and standardization of organoid assays.
Tech Stack
Microfluidics-on-chip3D cell cultureDroplet-based microfluidicsAI analysis platform
Team Size
Key Risks
Adoption of novel 3D organoid screening technology may face resistance from established 2D assay methods.
Competition from existing preclinical screening platforms with established market presence.
Scalability challenges in maintaining assay quality and consistency with high-throughput organoid screening.
Regulatory hurdles in translating 3D organoid screening results into clinical applications.
Opportunities
Leveraging AI-driven analysis to improve the accuracy and efficiency of drug screening.
Expanding into new therapeutic areas beyond oncology, such as toxicology and regenerative medicine.
Partnering with pharmaceutical companies to integrate Okomera's platform into their drug discovery workflows.
Developing a comprehensive database of organoid screening data to accelerate personalized medicine research.
Live Data Stream
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats